Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

ANI Pharmaceuticals

ANI Pharmaceuticals reported $67.76M in Cash and Equivalent for its fiscal quarter ending in March of 2023.

Cash And Equivalent Change
ANI Pharmaceuticals ANIP:US USD 67.76M 19.53M
Depomed DEPO:US USD 68.6M 3.66M
Eli Lilly LLY:US USD 3.55B 1.48B
Emergent BioSolutions EBS:US USD 430.2M 212.4M
Endo International ENDP:US USD 903.61M 115.27M
Heron Therapeutics HRTX:US USD 27.09M 11.73M
Hikma Pharmaceutical HIK:LN USD 1000K 22M
Knight Therapeutics Inc GUD:CN CAD 1.95M 1.65M
Nektar Therapeutics NKTR:US USD 76.96M 11.27M
Novartis NVS:US USD 12B 4.48B
Perrigo PRGO:US USD 553M 47.7M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2.14B 658M